KAIRA

Serial Number 79351233
Registration 7393879
700

Registration Progress

Application Filed
Aug 12, 2022
Under Examination
Approved for Publication
Feb 21, 2024
Published for Opposition
Mar 12, 2024
Registered
May 28, 2024

Basic Information

Serial Number
79351233
Registration Number
7393879
Filing Date
August 12, 2022
Registration Date
May 28, 2024
Published for Opposition
March 12, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 28, 2024
Registration
Registered
Classes
005

Rights Holder

OPTOLANE TECHNOLOGIES INC.

03
Address
6F, 20, Pangyoyeok-ro 241beon-gil,
Bundang-gu, Seongnam-si Gyeonggi-do 13494
KR

Ownership History

OPTOLANE TECHNOLOGIES INC.

Original Applicant
03
KR

OPTOLANE TECHNOLOGIES INC.

Owner at Publication
03
KR

OPTOLANE TECHNOLOGIES INC.

Original Registrant
03
KR

Legal Representation

Attorney
William E. Anderson

USPTO Deadlines

Next Deadline
1784 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-05-28)
Due Date
May 28, 2030
Grace Period Ends
November 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description
Nov 30, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 10, 2024 FIMP P FINAL DISPOSITION PROCESSED
Nov 10, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Aug 28, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 28, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 28, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Mar 25, 2024 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 12, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2024 PUBO A PUBLISHED FOR OPPOSITION
Mar 11, 2024 GPNX P NOTIFICATION PROCESSED BY IB
Mar 6, 2024 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 6, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 21, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2024 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 5, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 9, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 15, 2023 RFNT P REFUSAL PROCESSED BY IB
Jul 21, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 21, 2023 RFRR P REFUSAL PROCESSED BY MPU
Jun 16, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 15, 2023 CNRT R NON-FINAL ACTION WRITTEN
Jun 1, 2023 DOCK D ASSIGNED TO EXAMINER
Oct 4, 2022 MAFR O APPLICATION FILING RECEIPT MAILED
Sep 30, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Reagents for measurement of HBs antibody; glue coated strips for use against vermin; medicine cases, portable, filled, namely, medical diagnostic kits consisting primarily of clinical medical reagents being oligonucleotides, enzymes, and nucleotides, and also containing DNA primers and biochemical probes, fluorescent reference dye, and reaction buffers for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications; medical diagnostic reagents for immunization disease; mothproofing paper; bacterial preparations for veterinary purposes; reagent paper for veterinary purposes; reagents for use in veterinary genetic testing; milk sugar for pharmaceutical purposes; medicated plasters; cultures of microorganisms for medical use in dietary supplements and food supplements; reagent paper for medical purposes; reagents for use in medical genetic testing; preparations for detecting mutation in prion genes for medical purposes; chemical reagents for medical purposes; medical diagnostic reagents; chemical preparations for the diagnosis of pregnancy; diagnostic biomarker reagents for medical purposes; lining materials for dental purposes; Diagnostic preparations for medical purposes in the nature of preparations for diagnosing tuberculosis

Classification

International Classes
005